InvestorsHub Logo
Followers 28
Posts 4955
Boards Moderated 0
Alias Born 01/07/2020

Re: DMC8 post# 420357

Monday, 01/15/2024 6:33:11 AM

Monday, January 15, 2024 6:33:11 AM

Post# of 423618
DCM8, Thanks for a great article and 'follow up' - on Holts recent presentation on JP.

Here from the article:

Bottom line

AMRN is a buy at these prices - once again. My assessment is based on

a) Sarissa’s all-out endeavour to turn Amarin around,

b) Sarissa’s buying Amarin shares and not selling shares, putting money where their mouth is,

c) implementing some of the proposed strategies over which 80% shareholders voted for them,*

d) the new CEO’s previous expertise in the cardiovascular “turnaround” space,

e) Sarissa’s previous expertise in the same space with The Medicines Company, and f) the new earnings figures, which supports points a to e.

Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News